Come up with a name for your new list and we'll add to it:
Oncosimis Biotech raised a round of funding on January 14, 2017. Investors include
Centre for Cellular and Molecular Biology.
Oncosimis Biotech plans to establish processes in the production of biosimilars and develop a new process to prepare a number of cancer drugs.…